{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:17:58Z","timestamp":1782015478491,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Professor Nanna Svartz foundation"},{"name":"King Gustaf V 80-year foundation","award":["FAI2014-0040"],"award-info":[{"award-number":["FAI2014-0040"]}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"crossref","award":["SLS-412701"],"award-info":[{"award-number":["SLS-412701"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"crossref","award":["R-385481"],"award-info":[{"award-number":["R-385481"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"County Council of \u00d6sterg\u00f6tland","award":["LIO-387071"],"award-info":[{"award-number":["LIO-387071"]}]},{"DOI":"10.13039\/100010805","name":"Medical Research Council of Southeast Sweden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.trsl.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T20:19:44Z","timestamp":1412540384000},"page":"658-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"165","author":[{"given":"Christopher","family":"Sj\u00f6wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Martinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Cardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ekstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2014.09.007_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-11-91","article-title":"Non-invasive markers for hepatic fibrosis","volume":"11","author":"Baranova","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.trsl.2014.09.007_bib2","series-title":"Sleisenger and Fordtran's gastrointestinal and liver disease","author":"Feldman","year":"2010"},{"key":"10.1016\/j.trsl.2014.09.007_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archinte.1979.03630430043014","article-title":"Sampling variability on percutaneous liver biopsy","volume":"139","author":"Abdi","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trsl.2014.09.007_bib5","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2014.09.007_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2014.09.007_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","article-title":"Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort","volume":"57","author":"Holmberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trsl.2014.09.007_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrgastro.2013.197","article-title":"NAFLD\u2014the next global epidemic","volume":"10","author":"Ray","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2014.09.007_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2174\/13894501113146660215","article-title":"Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials","volume":"14","author":"Yilmaz","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.trsl.2014.09.007_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2014.09.007_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2","article-title":"Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression","volume":"180","author":"Wilhelm","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2014.09.007_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.trsl.2014.09.007_bib13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V76.9.1795.1795","article-title":"Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA","volume":"76","author":"Barnathan","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2014.09.007_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0038-1656003","article-title":"The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage","volume":"77","author":"Wohn","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2014.09.007_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajcp\/102.6.835","article-title":"Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue","volume":"102","author":"Plesner","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trsl.2014.09.007_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1083\/jcb.100.1.86","article-title":"A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase","volume":"100","author":"Vassalli","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2014.09.007_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.152.2.505","article-title":"Urokinase receptor: an activation antigen in human T lymphocytes","volume":"152","author":"Nykjaer","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2014.09.007_bib18","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.4049\/jimmunol.141.12.4229","article-title":"IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes","volume":"141","author":"Kirchheimer","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2014.09.007_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0037-1616105","article-title":"Release of soluble urokinase receptor from vascular cells","volume":"86","author":"Chavakis","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2014.09.007_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)01624-0","article-title":"Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in\u00a0vitro and in\u00a0vivo","volume":"475","author":"Sidenius","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.trsl.2014.09.007_bib21","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00134-012-2613-1","article-title":"Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review","volume":"38","author":"Backes","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.trsl.2014.09.007_bib22","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc11434","article-title":"Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study","volume":"16","author":"Haupt","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.trsl.2014.09.007_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1478-3231.2011.02665.x","article-title":"Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis","volume":"32","author":"Zimmermann","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2014.09.007_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-010-1149-y","article-title":"Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1","volume":"30","author":"Andersen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.trsl.2014.09.007_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCG.0b013e31822da19d","article-title":"Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection","volume":"46","author":"Berres","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2014.09.007_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.trsl.2013.07.003","article-title":"Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus","volume":"162","author":"Enocsson","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2014.09.007_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2014.09.007_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/modpathol.3800370","article-title":"Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting","volume":"18","author":"Franz\u00e9n","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trsl.2014.09.007_bib31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2014.09.007_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/00365520510015674","article-title":"Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers","volume":"40","author":"Islam","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2014.09.007_bib35","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2014.09.007_bib36","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2014.09.007_bib37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2014.09.007_bib38","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-013-2914-0","volume":"56","author":"Heraclides","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2014.09.007_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.trsl.2014.09.007_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MCG.0b013e31823a86f5","article-title":"Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis C virus","volume":"46","author":"Filik","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2014.09.007_bib41","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10096-011-1513-6","article-title":"Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C","volume":"31","author":"Usluer","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.trsl.2014.09.007_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/eci.12278","article-title":"Associations of suPAR with lifestyle and cardiometabolic risk factors","volume":"44","author":"Botha","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2014.09.007_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"Liver: an organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib44","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/liv.12512","article-title":"Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure","volume":"34","author":"Koch","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2014.09.007_bib45","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510290343","article-title":"Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor","volume":"29","author":"Fibbi","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib46","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2014.09.007_bib47","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2014.09.007_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2007-979470","article-title":"The role of cytokines and chemokines in the development of steatohepatitis","volume":"27","author":"Lalor","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.trsl.2014.09.007_bib49","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1093\/emboj\/16.24.7279","article-title":"A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity","volume":"16","author":"Fazioli","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.trsl.2014.09.007_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-008-9925-z","article-title":"Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR\/CD87)","volume":"321","author":"Pliyev","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.trsl.2014.09.007_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2014.09.007_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-009-9152-0","article-title":"Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis","volume":"33","author":"Pliyev","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.trsl.2014.09.007_bib53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/joim.12259","article-title":"Soluble urokinase plasminogen activator receptor, the candidate prophetic biomarker in severe inflammatory response syndrome","volume":"276","author":"Vasarhelyi","year":"2014","journal-title":"J Intern Med"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441400334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441400334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T13:23:36Z","timestamp":1717421016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152441400334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S193152441400334X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2014.09.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}